JoAnn V. Pinkerton, MD

Opinion

A new nonhormonal option for menopausal hot flashes: What prescribers should know

Author:: JoAnn V. Pinkerton, MD

Publish date: June 19, 2023

In two phase 3 clinical trials, fezolinetant 45 mg reduced the frequency of vasomotor symptoms by about 65%.

Article

Is vaginal estrogen used for GSM associated with a higher risk of CVD or cancer?

Author:: JoAnn V. Pinkerton, MD

Publish date: February 5, 2019

No. Vaginal estrogen use (average duration of use, 37.5 months) for genitourinary symptoms of menopa...

Article

Managing menopausal vasomotor and genitourinary symptoms after breast cancer

Author:: JoAnn V. Pinkerton, MD

Publish date: January 8, 2019

Two cases on selecting safe and useful treatments for survivors of breast cancer experiencing distressing quality-of-...

Audio

Managing menopausal symptoms in breast cancer survivors

Author:: JoAnn V. Pinkerton, MD

Publish date: May 3, 2018

What types of menopausal symptoms are breast cancer survivors faced with, and following breast cancer, what treatments should clinicians prioritize...

News

Conjugated estrogen plus bazedoxifene—a new approach to estrogen therapy

Author:: JoAnn V. Pinkerton, MD

Publish date: September 25, 2014

For which of my patients is this treatment appropriate?

Audio

Your menopausal patient’s breast biopsy reveals atypical hyperplasia

Author:: JoAnn V. Pinkerton, MD

Publish date: May 1, 2013

How do you now manage her menopausal symptoms, including bothersome hot flashes?

Audio

How I screen patients at increased risk for breast cancer

Author:: JoAnn V. Pinkerton, MD

Publish date: May 1, 2013

Hear Dr. Pinkerton discuss: How often women who are at high-risk for breast cancer should be screened New screening tools: breast tomosynth...

News

Can nonhormonal treatments relieve hot flushes in breast Ca survivors?

Author:: JoAnn V. Pinkerton, MD

Publish date: January 1, 2011

Yes. A Cochrane Review found clonidine, selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs), gab...

News

“Bioidentical” hormones: What you (and your patient) need to know

Author:: JoAnn V. Pinkerton, MD

Publish date: January 1, 2009

Here’s the skinny on compounded “bioidentical” hormone therapy—popular among women but absolutely data-free

News

Does the HRT-associated risk of breast cancer vary by histologic type and hormone regimen?

Author:: JoAnn V. Pinkerton, MD

Publish date: October 1, 2008

News

Q How common is hypoactive sexual desire disorder?

Author:: JoAnn V. Pinkerton, MD

Publish date: May 1, 2006